| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RASGRF1 RASGRF2 MYCBP2 ARHGEF5 GMIP RGS12 ARHGEF15 ARHGEF10L ARHGAP4 TBC1D10B ARAP3 RALGPS1 AGAP1 AGAP2 AGAP3 | 9.25e-06 | 507 | 154 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RASGRF1 RASGRF2 MYCBP2 ARHGEF5 GMIP RGS12 ARHGEF15 ARHGEF10L ARHGAP4 TBC1D10B ARAP3 RALGPS1 AGAP1 AGAP2 AGAP3 | 9.25e-06 | 507 | 154 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | microtubule binding | MAP1A GAS2L3 MAP4 KIF26A APC2 CAMSAP3 TOGARAM1 KIFC2 TTBK2 DST MACF1 | 2.80e-05 | 308 | 154 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | tubulin binding | MAP1A GAS2L3 MAP4 KIF26A APC2 CAMSAP3 WIPF3 TOGARAM1 KIFC2 TTBK2 DST MACF1 GNAS | 2.85e-05 | 428 | 154 | 13 | GO:0015631 |
| GeneOntologyMolecularFunction | GTPase activator activity | GMIP RGS12 ARHGEF15 ARHGEF10L ARHGAP4 TBC1D10B ARAP3 AGAP1 AGAP2 AGAP3 | 6.33e-05 | 279 | 154 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 5.40e-04 | 21 | 154 | 3 | GO:0042975 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | RASGRF1 ARHGEF5 APC2 GMIP ARHGEF15 TBC1D10B AGAP1 AGAP2 AGAP3 | 1.22e-07 | 109 | 153 | 9 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | RASGRF1 ARHGEF5 APC2 GMIP ARHGEF15 TBC1D10B ARAP3 AGAP1 AGAP2 AGAP3 | 1.46e-05 | 244 | 153 | 10 | GO:0043547 |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 3.72e-05 | 168 | 153 | 8 | GO:0031109 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 3.75e-05 | 51 | 153 | 5 | GO:0031111 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | RASGRF1 ARHGEF5 APC2 GMIP ARHGEF15 TBC1D10B ARAP3 PLXNC1 AGAP1 AGAP2 AGAP3 | 4.23e-05 | 335 | 153 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CARMIL2 MAP1A GAS2L3 MAP4 ARHGEF5 COL27A1 APC2 SH3KBP1 CAMSAP3 WIPF3 TOGARAM1 NCKAP5L EMILIN1 ARHGEF15 ARHGEF10L TTBK2 LDB3 CST3 INPP5J | 8.92e-05 | 957 | 153 | 19 | GO:0097435 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP1A GAS2L3 MAP4 APC2 CAMSAP3 CUL9 TOGARAM1 PARD3B NCKAP5L KIFC2 TTBK2 DST CCDC120 SAC3D1 CEP131 INPP5J | 9.25e-05 | 720 | 153 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 1.31e-04 | 66 | 153 | 5 | GO:0007019 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 1.55e-04 | 108 | 153 | 6 | GO:0031110 | |
| GeneOntologyBiologicalProcess | negative regulation of synapse maturation | 1.63e-04 | 3 | 153 | 2 | GO:2000297 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.77e-04 | 38 | 153 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | microtubule-based protein transport | 2.52e-04 | 17 | 153 | 3 | GO:0099118 | |
| GeneOntologyBiologicalProcess | protein transport along microtubule | 2.52e-04 | 17 | 153 | 3 | GO:0098840 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 2.62e-04 | 42 | 153 | 4 | GO:0031114 | |
| GeneOntologyCellularComponent | microtubule | MAP1A GAS2L3 MAP4 KIF26A APC2 CAMSAP3 AKNA TOGARAM1 NCKAP5L KIFC2 ARHGAP4 DST MACF1 CEP170B | 4.47e-05 | 533 | 155 | 14 | GO:0005874 |
| Domain | GAR | 9.58e-06 | 6 | 148 | 3 | PS51460 | |
| Domain | GAS2 | 9.58e-06 | 6 | 148 | 3 | PF02187 | |
| Domain | - | 9.58e-06 | 6 | 148 | 3 | 3.30.920.20 | |
| Domain | GAS_dom | 9.58e-06 | 6 | 148 | 3 | IPR003108 | |
| Domain | GAS2 | 9.58e-06 | 6 | 148 | 3 | SM00243 | |
| Domain | CH | 1.93e-05 | 70 | 148 | 6 | PF00307 | |
| Domain | CH | 2.46e-05 | 73 | 148 | 6 | PS50021 | |
| Domain | CH-domain | 2.87e-05 | 75 | 148 | 6 | IPR001715 | |
| Domain | PH_dom-like | RASGRF1 RASGRF2 ARHGEF5 RGS12 SH2B1 ARHGEF15 ARHGEF10L ARAP3 RALGPS1 EPB41L1 AGAP1 AGAP2 AGAP3 | 3.54e-05 | 426 | 148 | 13 | IPR011993 |
| Domain | - | RASGRF1 RASGRF2 ARHGEF5 RGS12 SH2B1 ARHGEF10L ARAP3 RALGPS1 EPB41L1 AGAP1 AGAP2 AGAP3 | 6.76e-05 | 391 | 148 | 12 | 2.30.29.30 |
| Domain | ArfGap | 7.71e-05 | 29 | 148 | 4 | SM00105 | |
| Domain | ARFGAP | 7.71e-05 | 29 | 148 | 4 | PS50115 | |
| Domain | ArfGap | 7.71e-05 | 29 | 148 | 4 | PF01412 | |
| Domain | ArfGAP | 7.71e-05 | 29 | 148 | 4 | IPR001164 | |
| Domain | PH | RASGRF1 RASGRF2 ARHGEF5 SH2B1 ARAP3 RALGPS1 AGAP1 AGAP2 AGAP3 | 8.97e-05 | 229 | 148 | 9 | PF00169 |
| Domain | MIRO-like | 1.32e-04 | 13 | 148 | 3 | IPR013684 | |
| Domain | Roc | 1.32e-04 | 13 | 148 | 3 | PF08477 | |
| Domain | DH_1 | 1.42e-04 | 63 | 148 | 5 | PS00741 | |
| Domain | CH | 1.65e-04 | 65 | 148 | 5 | SM00033 | |
| Domain | RhoGEF | 2.04e-04 | 68 | 148 | 5 | SM00325 | |
| Domain | RhoGEF | 2.34e-04 | 70 | 148 | 5 | PF00621 | |
| Domain | DH_2 | 2.34e-04 | 70 | 148 | 5 | PS50010 | |
| Domain | - | 2.50e-04 | 71 | 148 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 2.50e-04 | 71 | 148 | 5 | IPR000219 | |
| Domain | - | 2.50e-04 | 71 | 148 | 5 | 1.10.418.10 | |
| Domain | SH3 | 3.31e-04 | 216 | 148 | 8 | PS50002 | |
| Domain | SH3_domain | 3.75e-04 | 220 | 148 | 8 | IPR001452 | |
| Domain | PH | RASGRF1 RASGRF2 ARHGEF5 SH2B1 ARAP3 RALGPS1 AGAP1 AGAP2 AGAP3 | 3.81e-04 | 278 | 148 | 9 | SM00233 |
| Domain | PH_DOMAIN | RASGRF1 RASGRF2 ARHGEF5 SH2B1 ARAP3 RALGPS1 AGAP1 AGAP2 AGAP3 | 3.91e-04 | 279 | 148 | 9 | PS50003 |
| Domain | PH_domain | RASGRF1 RASGRF2 ARHGEF5 SH2B1 ARAP3 RALGPS1 AGAP1 AGAP2 AGAP3 | 4.01e-04 | 280 | 148 | 9 | IPR001849 |
| Domain | SH3_2 | 6.07e-04 | 86 | 148 | 5 | PF07653 | |
| Domain | SH3_2 | 6.07e-04 | 86 | 148 | 5 | IPR011511 | |
| Domain | FYrich_C | 6.14e-04 | 5 | 148 | 2 | IPR003889 | |
| Domain | FYrich_N | 6.14e-04 | 5 | 148 | 2 | IPR003888 | |
| Domain | FYRC | 6.14e-04 | 5 | 148 | 2 | SM00542 | |
| Domain | FYRN | 6.14e-04 | 5 | 148 | 2 | SM00541 | |
| Domain | FYRN | 6.14e-04 | 5 | 148 | 2 | PF05964 | |
| Domain | FYRC | 6.14e-04 | 5 | 148 | 2 | PF05965 | |
| Domain | FYRC | 6.14e-04 | 5 | 148 | 2 | PS51543 | |
| Domain | FYRN | 6.14e-04 | 5 | 148 | 2 | PS51542 | |
| Domain | EPHD | 6.72e-04 | 22 | 148 | 3 | PS51805 | |
| Domain | - | 9.16e-04 | 6 | 148 | 2 | 3.90.1290.10 | |
| Domain | F_BAR | 9.87e-04 | 25 | 148 | 3 | IPR031160 | |
| Domain | F_BAR | 9.87e-04 | 25 | 148 | 3 | PS51741 | |
| Domain | RASGEF | 1.11e-03 | 26 | 148 | 3 | PS00720 | |
| Domain | AT_hook | 1.24e-03 | 27 | 148 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.24e-03 | 27 | 148 | 3 | IPR017956 | |
| Domain | APC_su10/DOC_dom | 1.28e-03 | 7 | 148 | 2 | IPR004939 | |
| Domain | Plectin | 1.28e-03 | 7 | 148 | 2 | PF00681 | |
| Domain | DOC | 1.28e-03 | 7 | 148 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.28e-03 | 7 | 148 | 2 | PF03256 | |
| Domain | Plectin_repeat | 1.28e-03 | 7 | 148 | 2 | IPR001101 | |
| Domain | APC10 | 1.28e-03 | 7 | 148 | 2 | SM01337 | |
| Domain | PLEC | 1.28e-03 | 7 | 148 | 2 | SM00250 | |
| Domain | RASGEF_CAT | 1.53e-03 | 29 | 148 | 3 | PS50009 | |
| Domain | RasGEF | 1.69e-03 | 30 | 148 | 3 | PF00617 | |
| Domain | - | 1.69e-03 | 30 | 148 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.69e-03 | 30 | 148 | 3 | IPR001895 | |
| Domain | RasGEF | 1.69e-03 | 30 | 148 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 1.69e-03 | 30 | 148 | 3 | IPR023578 | |
| Domain | fn3 | 1.86e-03 | 162 | 148 | 6 | PF00041 | |
| Domain | - | 2.31e-03 | 70 | 148 | 4 | 2.10.110.10 | |
| Domain | LIM | 2.44e-03 | 71 | 148 | 4 | SM00132 | |
| Domain | Znf_LIM | 2.44e-03 | 71 | 148 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 2.44e-03 | 71 | 148 | 4 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 2.44e-03 | 71 | 148 | 4 | PS50023 | |
| Pathway | PID_RHOA_REG_PATHWAY | 2.24e-05 | 46 | 105 | 5 | M68 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 7.08e-05 | 94 | 105 | 6 | MM15598 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 9.07e-05 | 142 | 105 | 7 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.23e-04 | 149 | 105 | 7 | M41805 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | RASGRF2 ARHGEF5 WIPF3 GMIP ARHGEF15 ARHGEF10L ZNF512B ARHGAP4 DST ARAP3 RBMX SPEN | 1.28e-04 | 450 | 105 | 12 | M27078 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.57e-04 | 155 | 105 | 7 | M41808 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | RASGRF2 ARHGEF5 GMIP ARHGEF15 ARHGEF10L ZNF512B ARHGAP4 DST ARAP3 RBMX SPEN | 4.22e-04 | 439 | 105 | 11 | MM15595 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.47e-04 | 184 | 105 | 7 | M41809 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MPP3 CRYBG2 ANKS6 KMT2B MYCBP2 KIF26A SPEG AKNA C15orf39 CUL9 FHIP1B KIFC2 ARHGEF10L C6orf132 MICALL1 PKMYT1 SCAF1 NCOR2 KMT2D DST ARAP3 TULP4 RALGPS1 BRD4 SAC3D1 MLLT6 CEP131 WDR90 SNAPC4 MBD5 SPEN CEP170B SOWAHB AGAP3 | 1.04e-18 | 1105 | 160 | 34 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ITCH CARMIL2 TTC28 MYCBP2 MAP4 ARHGEF5 CAMSAP3 PARD3B KIAA1191 NCKAP5L SPECC1 RGS12 C6orf132 MICALL1 USP31 TBC1D10B BMPR2 DST BRD4 MACF1 CEP131 GNAS DCLK1 CEP170B EPB41L1 AGAP3 | 3.03e-14 | 861 | 160 | 26 | 36931259 |
| Pubmed | MAP1A RASGRF1 MYCBP2 MAP4 WDR7 SH3KBP1 CAMSAP3 HCN2 SPECC1 BMPR2 DST AJM1 MACF1 PRRC2A DCLK1 CEP170B EPB41L1 AGAP2 | 4.68e-14 | 347 | 160 | 18 | 17114649 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MAP1A TCOF1 TSPOAP1 ARHGEF5 APC2 FAM186B SH2B1 C6orf132 NCOR2 LARP4B TULP4 ATXN2 NFATC4 MLLT6 WDR90 MGA SPEN | 1.84e-11 | 430 | 160 | 17 | 35044719 |
| Pubmed | ITCH MAP1A TTC28 TCOF1 ATXN7L1 CUL9 ZC3H18 NCKAP5L FBXL6 ZNF512B ARHGAP4 SCAF1 MSH6 NCOR2 TBC1D10B LARP4B BCL11B BRD4 FOXL2NB MACF1 TAF4B MGA IRX2 CEP170B AGAP3 | 6.36e-11 | 1116 | 160 | 25 | 31753913 | |
| Pubmed | ITCH TCOF1 PRR36 MYCBP2 WDR7 APC2 SH3KBP1 CAMSAP3 HCN2 CCDC177 NCOR2 BCL11B DST ATXN2 MACF1 CEP131 MGA PRRC2A GOLGA1 DCLK1 CEP170B EPB41L1 AGAP2 | 1.15e-10 | 963 | 160 | 23 | 28671696 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | MAP1A MAP4 HMGA1 NCKAP5L NCOR2 KMT2D RBMX CEP131 MGA SPEN CEP170B | 1.05e-09 | 184 | 160 | 11 | 32908313 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B TCOF1 MYCBP2 MAP4 CAMSAP3 ZC3H18 HMGA1 MICALL1 SCAF1 MSH6 NCOR2 TBC1D10B KMT2D RBMX BRD4 SAC3D1 SNAPC4 SPEN PRRC2A | 3.49e-09 | 774 | 160 | 19 | 15302935 |
| Pubmed | AMPH CARMIL2 MAP1A PRR36 MAP4 WDR7 SH3KBP1 ZNF185 CAMSAP3 CCDC177 SPECC1 ARCN1 USP31 DST AJM1 RBMX SORCS2 MACF1 PRRC2A DCLK1 CEP170B EPB41L1 AGAP2 AGAP3 | 4.43e-08 | 1431 | 160 | 24 | 37142655 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | AMPH MAP1A WDR7 CAMSAP3 MACF1 GNAS DCLK1 CEP170B EPB41L1 AGAP1 AGAP2 | 8.43e-08 | 281 | 160 | 11 | 28706196 |
| Pubmed | APC2 CAMSAP3 FCHO2 HCN2 CCDC177 SPECC1 TBC1D10B MACF1 CEP170B EPB41L1 AGAP1 AGAP2 AGAP3 | 1.12e-07 | 430 | 160 | 13 | 32581705 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | RASGRF1 MYCBP2 MAP4 TOGARAM1 ZC3H18 HMGA1 SCAF1 DCAF10 RBMX MACF1 SPEN PRRC2A | 1.27e-07 | 361 | 160 | 12 | 26167880 |
| Pubmed | AMPH MAP1A MYCBP2 MAP4 TSPOAP1 NACA SH3KBP1 CAMSAP3 HMGA1 NFS1 ARCN1 LARP4B AJM1 MACF1 CEP131 DCLK1 CEP170B EPB41L1 AGAP2 AGAP3 | 3.21e-07 | 1139 | 160 | 20 | 36417873 | |
| Pubmed | KMT2B MAP4 SH3KBP1 CUL9 NFS1 HCN2 KIFC2 TULP4 BRD4 KCNN1 SPEN | 4.07e-07 | 329 | 160 | 11 | 17474147 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MAP1A TTC28 TCOF1 C15orf39 CUL9 ZC3H18 NCKAP5L NCOR2 PPP4R2 MACF1 CEP131 GNAS SPEN CEP170B | 6.43e-07 | 588 | 160 | 14 | 38580884 |
| Pubmed | TCOF1 MAP4 CAMSAP3 FCHO2 MSH6 LARP4B RBMX CEP131 SPEN CDCA5 PRRC2A EPB41L1 AGAP3 | 6.61e-07 | 503 | 160 | 13 | 16964243 | |
| Pubmed | CEBPD KMT2B MYCBP2 MAP4 C15orf39 HMGA1 TGIF1 MSH6 NCOR2 KMT2D ATXN2 PPP4R2 RBMX BRD4 SUGP1 MLLT6 SPEN CDCA5 PRRC2A | 8.60e-07 | 1103 | 160 | 19 | 34189442 | |
| Pubmed | RASGRF2 PRR36 ARHGEF5 NACA SH3KBP1 DUT CAMSAP3 GMIP ARHGEF15 ARCN1 ARHGEF10L ARHGAP4 ARAP3 MGA CDCA5 PRRC2A AGAP3 | 1.24e-06 | 916 | 160 | 17 | 32203420 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.36e-06 | 231 | 160 | 9 | 16452087 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CABLES2 ITCH MYCBP2 MAP4 ATXN7L1 CAMSAP3 PARD3B ZNF767P SH2B1 NCOR2 BMPR2 TULP4 ATXN2 RALGPS1 MACF1 GNAS MBD5 PRDM15 CEP170B EPB41L1 AGAP1 AGAP3 | 1.43e-06 | 1489 | 160 | 22 | 28611215 |
| Pubmed | KMT2B MAP4 NACA CAMSAP3 ZNF767P SPECC1 C6orf132 FBXL6 SCAF1 MSH6 LARP4B DST ATXN2 MACF1 CEP131 SPEN PRRC2A DCLK1 CEP170B EPB41L1 AGAP1 AGAP3 | 1.56e-06 | 1497 | 160 | 22 | 31527615 | |
| Pubmed | ITCH TTC28 TCOF1 MYCBP2 APC2 CUL9 ADAMTS8 SPECC1 SH2B1 ARCN1 ZNF512B RNF123 DST KCNN1 MACF1 PRRC2A DCLK1 AGAP1 AGAP2 AGAP3 | 2.06e-06 | 1285 | 160 | 20 | 35914814 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAP4 SH3KBP1 ZNF185 SPECC1 C6orf132 MICALL1 TBC1D10B BMPR2 DST MACF1 CCDC120 JPT1 EPB41L1 | 2.39e-06 | 565 | 160 | 13 | 25468996 |
| Pubmed | 2.51e-06 | 130 | 160 | 7 | 12421765 | ||
| Pubmed | KMT2B ATXN7L1 NACA SH3KBP1 C15orf39 CUL9 ZC3H18 ZNF512B NCOR2 LARP4B KMT2D MIDN DST ATXN2 NFATC4 SUGP1 MLLT6 CEP131 MGA SPEN PRRC2A | 2.75e-06 | 1429 | 160 | 21 | 35140242 | |
| Pubmed | TTC28 WDR7 TSPOAP1 SPEG CUL9 FHIP1B USP31 MACF1 SPEN CEP170B EPB41L1 | 3.22e-06 | 407 | 160 | 11 | 12693553 | |
| Pubmed | KMT2B TTC28 MYCBP2 CAMSAP3 C15orf39 NCOR2 KMT2D DST BRD4 CEP131 MGA | 4.15e-06 | 418 | 160 | 11 | 34709266 | |
| Pubmed | CABLES2 ITCH PARD3B FCHO2 SPECC1 USP31 TBC1D10B DST MACF1 EPB41L1 AGAP1 | 4.44e-06 | 421 | 160 | 11 | 36976175 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GAS2L3 TCOF1 MYCBP2 MAP4 NACA HMGA1 SPECC1 ARCN1 ZNF512B SCAF1 DST RBMX MACF1 CEP131 GNAS MGA SPEN | 5.48e-06 | 1024 | 160 | 17 | 24711643 |
| Pubmed | MYCBP2 DUSP2 CAMSAP3 HMGA1 FCHO2 NCKAP5L ZNF512B USP31 MSH6 NCOR2 TBC1D10B KMT2D ATXN2 PPP4R2 CEP131 PRRC2A EPB41L1 | 7.51e-06 | 1049 | 160 | 17 | 27880917 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 7.87e-06 | 9 | 160 | 3 | 12640130 | |
| Pubmed | 8.54e-06 | 103 | 160 | 6 | 32744500 | ||
| Pubmed | KMT2B TTC28 TCOF1 MYCBP2 MAP4 ARCN1 MSH6 KMT2D BRD4 MGA SPEN PRRC2A | 9.87e-06 | 549 | 160 | 12 | 38280479 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | ANKS6 MYCBP2 CAMSAP3 C15orf39 ZC3H18 C6orf132 CCDC120 DCLK1 AGAP3 | 1.36e-05 | 307 | 160 | 9 | 37499664 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ANKS6 ITCH CARMIL2 FCHO2 SPECC1 RGS12 MICALL1 TBC1D10B SLITRK2 PLXNC1 EPB41L1 AGAP1 | 1.41e-05 | 569 | 160 | 12 | 30639242 |
| Pubmed | COL27A1 TOGARAM1 KIAA1191 SH2B1 ARHGEF15 LARP4B LDB3 TULP4 MACF1 MBD5 MGA | 1.94e-05 | 493 | 160 | 11 | 15368895 | |
| Pubmed | 1.98e-05 | 246 | 160 | 8 | 15345747 | ||
| Pubmed | RASGRF2 controls nuclear migration in postnatal retinal cone photoreceptors. | 2.10e-05 | 2 | 160 | 2 | 26743081 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 20064471 | ||
| Pubmed | The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass. | 2.10e-05 | 2 | 160 | 2 | 24550008 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12388557 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11002341 | ||
| Pubmed | RBMX is a component of the centromere noncoding RNP complex involved in cohesion regulation. | 2.10e-05 | 2 | 160 | 2 | 29383807 | |
| Pubmed | Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. | 2.10e-05 | 2 | 160 | 2 | 21796119 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27693509 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16467520 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 35640156 | ||
| Pubmed | A dual role for the RhoGEF Ephexin5 in regulation of dendritic spine outgrowth. | 2.10e-05 | 2 | 160 | 2 | 28185854 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28966131 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17141611 | ||
| Pubmed | The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3. | 2.10e-05 | 2 | 160 | 2 | 16079295 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27802168 | ||
| Pubmed | Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders. | 2.10e-05 | 2 | 160 | 2 | 35506254 | |
| Pubmed | The Inhibition of RasGRF2, But Not RasGRF1, Alters Cocaine Reward in Mice. | 2.10e-05 | 2 | 160 | 2 | 31182637 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19193896 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 14749369 | ||
| Pubmed | A murine CDC25/ras-GRF-related protein implicated in Ras regulation. | 2.10e-05 | 2 | 160 | 2 | 8293576 | |
| Pubmed | 2.29e-05 | 251 | 160 | 8 | 31076518 | ||
| Pubmed | 2.75e-05 | 76 | 160 | 5 | 27542412 | ||
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 3.66e-05 | 133 | 160 | 6 | 15604093 | |
| Pubmed | KIF26A NACA AKNA ARHGEF10L MICALL1 ZNF512B ARHGAP4 DST RALGPS1 WDR90 AGAP1 | 3.68e-05 | 529 | 160 | 11 | 14621295 | |
| Pubmed | TTC28 TCOF1 SPCS1 ZNF185 CUL9 ZC3H18 SPECC1 MSH6 DST AEBP2 MACF1 EPB41L1 | 4.04e-05 | 634 | 160 | 12 | 34591612 | |
| Pubmed | Directional neuronal migration is impaired in mice lacking adenomatous polyposis coli 2. | 4.17e-05 | 15 | 160 | 3 | 22573669 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TTC28 ZNF185 CAMSAP3 PARD3B KIAA1191 FCHO2 FHIP1B NCKAP5L RGS12 ARCN1 MICALL1 CEP41 MGA CEP170B | 4.34e-05 | 853 | 160 | 14 | 28718761 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.34e-05 | 283 | 160 | 8 | 30585729 | |
| Pubmed | TCOF1 MYCBP2 MAP4 CUL9 ZC3H18 MSH6 LARP4B DST RBMX MACF1 SPEN PRRC2A | 5.36e-05 | 653 | 160 | 12 | 22586326 | |
| Pubmed | 5.49e-05 | 209 | 160 | 7 | 36779422 | ||
| Pubmed | TCOF1 MAP4 CAMSAP3 ZC3H18 NFS1 MSH6 NCOR2 LARP4B DCAF10 PPP4R2 GNAS PRRC2A | 5.52e-05 | 655 | 160 | 12 | 35819319 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 5.83e-05 | 370 | 160 | 9 | 22922362 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 36228617 | ||
| Pubmed | RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. | 6.29e-05 | 3 | 160 | 2 | 21685891 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 32544095 | ||
| Pubmed | Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N. | 6.29e-05 | 3 | 160 | 2 | 11136977 | |
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 6.29e-05 | 3 | 160 | 2 | 12399109 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 23358417 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 24268649 | ||
| Pubmed | Targeted disruption of Ras-Grf2 shows its dispensability for mouse growth and development. | 6.29e-05 | 3 | 160 | 2 | 11909944 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 27045138 | ||
| Pubmed | HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1. | 6.29e-05 | 3 | 160 | 2 | 27725726 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 28346227 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 15029245 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 6.73e-05 | 377 | 160 | 9 | 38117590 | |
| Pubmed | CRYBG2 TTC28 PARD3B ZC3H18 HMGA1 LARP4B KMT2D BRD4 AEBP2 SPEN | 6.80e-05 | 469 | 160 | 10 | 27634302 | |
| Pubmed | 8.02e-05 | 222 | 160 | 7 | 37071664 | ||
| Pubmed | 8.96e-05 | 226 | 160 | 7 | 31452512 | ||
| Pubmed | 9.31e-05 | 98 | 160 | 5 | 34943047 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ANKS6 TCOF1 C15orf39 CAVIN3 GMIP KIAA1191 FCHO2 NCKAP5L ARCN1 LARP4B ARAP3 CEP41 SUGP1 GNAS AGAP1 | 9.62e-05 | 1038 | 160 | 15 | 26673895 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | KMT2B MYCBP2 ZNF689 SPECC1 FBXL6 ZNF512B KMT2D AEBP2 MBD5 MGA | 1.06e-04 | 495 | 160 | 10 | 27705803 |
| Pubmed | MAP1A COL27A1 CUL9 ZC3H18 HMGA1 EMILIN1 MSH6 MACF1 TAF4B PRRC2A | 1.08e-04 | 496 | 160 | 10 | 31343991 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP1A TCOF1 MAP4 NACA DUT HMGA1 ARCN1 ZNF512B MSH6 DST SUGP1 MACF1 JPT1 PRRC2A | 1.13e-04 | 934 | 160 | 14 | 33916271 |
| Pubmed | TTC28 TCOF1 MAP4 ZC3H18 FCHO2 ARCN1 MICALL1 TBC1D10B DST MACF1 PRRC2A EPB41L1 | 1.15e-04 | 708 | 160 | 12 | 39231216 | |
| Pubmed | 1.18e-04 | 103 | 160 | 5 | 10574462 | ||
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 1.25e-04 | 4 | 160 | 2 | 19221051 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 20808952 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 23826075 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 16129689 | ||
| Pubmed | DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4. | 1.25e-04 | 4 | 160 | 2 | 30057199 | |
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 1.25e-04 | 4 | 160 | 2 | 23129768 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 19692568 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 8954775 | ||
| Interaction | MAPRE3 interactions | MAP1A TTC28 GAS2L3 MAP4 APC2 CAMSAP3 NCKAP5L SPECC1 C6orf132 TTBK2 LARP4B DST MACF1 CEP131 PRRC2A DCLK1 CEP170B | 2.52e-12 | 230 | 155 | 17 | int:MAPRE3 |
| Interaction | TOP3B interactions | MPP3 CRYBG2 ANKS6 KMT2B MYCBP2 KIF26A SPEG AKNA C15orf39 CUL9 FHIP1B KIFC2 ARHGEF10L C6orf132 FBXL6 MICALL1 PKMYT1 SCAF1 NCOR2 LARP4B KMT2D DST ARAP3 TULP4 ATXN2 RALGPS1 BRD4 SAC3D1 MLLT6 CEP131 WDR90 GNAS SNAPC4 MBD5 SPEN PRRC2A CEP170B SOWAHB AGAP3 | 4.69e-12 | 1470 | 155 | 39 | int:TOP3B |
| Interaction | DCTN1 interactions | MAP1A GAS2L3 PRR36 MYCBP2 MAP4 NACA CAMSAP3 NCKAP5L SPECC1 ZNF512B MSH6 DST PPP4R2 CEP41 MACF1 CEP131 DCLK1 CEP170B AGAP3 | 9.70e-09 | 497 | 155 | 19 | int:DCTN1 |
| Interaction | YWHAB interactions | CARMIL2 TTC28 RASGRF1 MYCBP2 ARHGEF5 SPEG CAMSAP3 PARD3B NCKAP5L SPECC1 RGS12 C6orf132 MICALL1 USP31 TBC1D10B DST RALGPS1 RBMX MACF1 CEP131 DCLK1 CEP170B EPB41L1 AGAP1 AGAP2 AGAP3 | 6.05e-08 | 1014 | 155 | 26 | int:YWHAB |
| Interaction | YWHAE interactions | CARMIL2 TTC28 RASGRF1 MYCBP2 ARHGEF5 CAMSAP3 PARD3B ZC3H18 HMGA1 NCKAP5L SPECC1 RGS12 C6orf132 MICALL1 USP31 NCOR2 MIDN DST BRD4 MACF1 CEP131 MGA PRRC2A DCLK1 CEP170B EPB41L1 AGAP1 AGAP3 | 3.19e-07 | 1256 | 155 | 28 | int:YWHAE |
| Interaction | TRIM36 interactions | MAP1A GAS2L3 MAP4 CAMSAP3 SPECC1 ZNF512B USP31 DCLK1 CEP170B | 1.75e-06 | 144 | 155 | 9 | int:TRIM36 |
| Interaction | YWHAZ interactions | CARMIL2 TTC28 RASGRF1 RASGRF2 MYCBP2 WDR7 ARHGEF5 SPEG CAMSAP3 PARD3B ZC3H18 NCKAP5L SPECC1 RGS12 C6orf132 MICALL1 USP31 DST NFATC4 BRD4 MACF1 CEP131 PRRC2A DCLK1 CEP170B EPB41L1 AGAP1 | 2.74e-06 | 1319 | 155 | 27 | int:YWHAZ |
| Interaction | YWHAH interactions | CARMIL2 TTC28 MYCBP2 ARHGEF5 SPEG CAMSAP3 PARD3B KIAA1191 NCKAP5L SPECC1 RGS12 C6orf132 MICALL1 USP31 TBC1D10B DST BRD4 MACF1 CEP131 DCLK1 CEP170B EPB41L1 AGAP1 AGAP3 | 3.74e-06 | 1102 | 155 | 24 | int:YWHAH |
| Interaction | SYNGAP1 interactions | AMPH MAP1A MYCBP2 MAP4 WDR7 SH3KBP1 FCHO2 GNAS EPB41L1 AGAP1 AGAP2 AGAP3 | 4.70e-06 | 307 | 155 | 12 | int:SYNGAP1 |
| Interaction | SFN interactions | ITCH MAP1A MYCBP2 MAP4 ARHGEF5 CAMSAP3 PARD3B ZC3H18 NCKAP5L SPECC1 RGS12 C6orf132 USP31 DST RBMX MACF1 CEP131 CEP170B | 6.52e-06 | 692 | 155 | 18 | int:SFN |
| Interaction | RCOR1 interactions | KMT2B TTC28 MYCBP2 CAMSAP3 C15orf39 HMGA1 NCKAP5L MSH6 NCOR2 KMT2D DST BRD4 CEP131 MGA SPEN | 6.59e-06 | 494 | 155 | 15 | int:RCOR1 |
| Interaction | SLC6A4 interactions | DUSP2 APC2 CAMSAP3 FCHO2 HCN2 CCDC177 SPECC1 TBC1D10B MACF1 CEP170B EPB41L1 AGAP1 AGAP2 AGAP3 | 7.42e-06 | 437 | 155 | 14 | int:SLC6A4 |
| Interaction | SSPOP interactions | 1.53e-05 | 7 | 155 | 3 | int:SSPOP | |
| Interaction | YWHAQ interactions | ITCH CARMIL2 TTC28 MYCBP2 MAP4 ARHGEF5 SPEG CAMSAP3 PARD3B NCKAP5L SPECC1 RGS12 C6orf132 USP31 DST NFATC4 BRD4 MACF1 CEP131 DCLK1 CEP170B EPB41L1 AGAP1 | 1.53e-05 | 1118 | 155 | 23 | int:YWHAQ |
| Interaction | YWHAG interactions | ITCH CARMIL2 TTC28 MYCBP2 ARHGEF5 SPEG CAMSAP3 PARD3B NCKAP5L SPECC1 RGS12 C6orf132 MICALL1 USP31 TBC1D10B DST MACF1 CEP131 GNAS DCLK1 CEP170B EPB41L1 AGAP1 AGAP3 | 2.95e-05 | 1248 | 155 | 24 | int:YWHAG |
| Interaction | MAPRE1 interactions | APC2 CAMSAP3 KIAA1191 NCKAP5L SPECC1 TTBK2 DST BRD4 MACF1 CEP131 WDR90 PRRC2A GOLGA1 CEP170B | 4.47e-05 | 514 | 155 | 14 | int:MAPRE1 |
| Interaction | DPYSL2 interactions | ITCH MAP1A MAP4 NACA CAVIN3 FAM186B MICALL1 LARP4B RNF123 BRD4 AGAP2 | 4.71e-05 | 327 | 155 | 11 | int:DPYSL2 |
| Interaction | RAC1 interactions | ITCH CARMIL2 RASGRF1 RASGRF2 DUSP2 GMIP FCHO2 NCKAP5L SPECC1 MICALL1 ARHGAP4 TBC1D10B BMPR2 MIDN DST RBMX MACF1 GNAS EPB41L1 AGAP1 AGAP2 | 6.69e-05 | 1063 | 155 | 21 | int:RAC1 |
| Interaction | CEBPA interactions | ITCH CEBPD KMT2B RASGRF1 MYCBP2 MAP4 C15orf39 HMGA1 TGIF1 MSH6 NCOR2 KMT2D ATXN2 NFATC4 PPP4R2 RBMX BRD4 SUGP1 MACF1 MLLT6 SPEN CDCA5 PRRC2A | 8.12e-05 | 1245 | 155 | 23 | int:CEBPA |
| Interaction | SRPK2 interactions | MPP3 RASGRF1 TCOF1 MYCBP2 MAP4 TOGARAM1 ZC3H18 HMGA1 FBXL6 SCAF1 DCAF10 RBMX MACF1 SPEN PRRC2A EPB41L1 | 1.34e-04 | 717 | 155 | 16 | int:SRPK2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | MEF2B PEX11G PRR36 C19orf67 APC2 CAMSAP3 GMIP HCN2 MIDN BRD4 SUGP1 KCNN1 LYL1 | 5.00e-06 | 797 | 160 | 13 | chr19p13 |
| Cytoband | 12q13.12 | 3.20e-04 | 38 | 160 | 3 | 12q13.12 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.33e-05 | 206 | 103 | 8 | 682 | |
| GeneFamily | ArfGAPs | 3.58e-05 | 33 | 103 | 4 | 395 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.69e-05 | 66 | 103 | 5 | 722 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.15e-04 | 17 | 103 | 3 | 1291 | |
| GeneFamily | LIM domain containing | 3.55e-04 | 59 | 103 | 4 | 1218 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.77e-04 | 25 | 103 | 3 | 775 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.80e-04 | 8 | 103 | 2 | 939 | |
| GeneFamily | Fibronectin type III domain containing | 2.22e-03 | 160 | 103 | 5 | 555 | |
| GeneFamily | Ankyrin repeat domain containing | 2.62e-03 | 242 | 103 | 6 | 403 | |
| GeneFamily | T-boxes | 4.63e-03 | 18 | 103 | 2 | 766 | |
| Coexpression | LIAO_METASTASIS | GAS2L3 MAP4 NACA HMGA1 KIFC2 SH2B1 MICALL1 ARHGAP4 PLXNC1 ALPK3 HES4 SAC3D1 GNAS SNAPC4 PRRC2A | 1.22e-06 | 540 | 160 | 15 | M13809 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | AMPH ANKS6 CEBPD KIF26A SPEG DUSP2 WIPF3 C15orf39 CAVIN3 SEMA3G NCKAP5L ADAM8 EMILIN1 ARHGEF15 FBXL6 MICALL1 TBX18 SCAF1 MIDN ARAP3 SORCS2 GNAS FAM181B LYL1 | 3.23e-06 | 1143 | 156 | 24 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 | AMPH PRR36 ARHGEF5 ZNF185 CAMSAP3 WIPF3 C15orf39 HMGA1 ARHGEF10L C6orf132 PKMYT1 USP31 TGIF1 MIDN BCL11B RALGPS1 SORCS2 CCDC120 MLLT6 JPT1 IRX2 CEP170B EPB41L1 | 5.26e-05 | 1266 | 156 | 23 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | MPP3 AEN AMPH TSPOAP1 SPEG PAXX WIPF3 HMGA1 NCKAP5L ADAM8 SH2B1 ARHGEF10L PKMYT1 TGIF1 SCAF1 MIDN BCL11B RALGPS1 CCDC120 SAC3D1 MLLT6 PRRC2A CEP170B | 5.86e-05 | 1275 | 156 | 23 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 174 | 159 | 8 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 174 | 159 | 8 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-07 | 193 | 159 | 8 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | COVID-19_Severe-cDC|COVID-19_Severe / disease group, cell group and cell class | 5.22e-07 | 195 | 159 | 8 | 6419090b19de7b5d5140eaecf231860273da2c0d | |
| ToppCell | COVID-19_Moderate-cDC|World / disease group, cell group and cell class | 5.43e-07 | 196 | 159 | 8 | 92a236adf386f05d020b1954bbdc5bd32346cbf0 | |
| ToppCell | Healthy-cDC|Healthy / disease group, cell group and cell class | 5.86e-07 | 198 | 159 | 8 | 4cf874333b9fd6cd22ee647cd12c032fc6d05740 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.86e-07 | 198 | 159 | 8 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.86e-07 | 198 | 159 | 8 | e2038d9239e23d670d539f1c58475fd0de028e51 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-06 | 163 | 159 | 7 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.28e-06 | 166 | 159 | 7 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 176 | 159 | 7 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 176 | 159 | 7 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 176 | 159 | 7 | bfbab3c5b738b3b0b1540f2059d0245fbd8c0031 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-06 | 176 | 159 | 7 | ea27e18407b8a13e8212830da859efeb8f158690 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-06 | 180 | 159 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-06 | 180 | 159 | 7 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-06 | 180 | 159 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-06 | 181 | 159 | 7 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 183 | 159 | 7 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 183 | 159 | 7 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 185 | 159 | 7 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 185 | 159 | 7 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-06 | 185 | 159 | 7 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.01e-06 | 187 | 159 | 7 | 5917bdfe84cf5941e21b415aebbab3090cc5d576 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-06 | 187 | 159 | 7 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.38e-06 | 189 | 159 | 7 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.57e-06 | 190 | 159 | 7 | 4b25d49f033bbd326b47cf5602af3f0262cfc367 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.57e-06 | 190 | 159 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.96e-06 | 192 | 159 | 7 | 8e606eae3e5b07a856d3c2a74186d486da96309c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 193 | 159 | 7 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 193 | 159 | 7 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.17e-06 | 193 | 159 | 7 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.38e-06 | 194 | 159 | 7 | a94f9f7179a5733e3c378ff8b337e288785433a1 | |
| ToppCell | Bronchial_Brush-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.38e-06 | 194 | 159 | 7 | dbcc00940538efc0f89f074dbe822c50efa5ad8e | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.60e-06 | 195 | 159 | 7 | dd28c63b53f2a97e3fac127294a465870dc371b3 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.60e-06 | 195 | 159 | 7 | 0fcc41cda3e5f921748cf7e7fe48dd7ca1de4636 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-06 | 195 | 159 | 7 | d6ff38535898f90be6719cd5152291f2f4f8a746 | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.82e-06 | 196 | 159 | 7 | e1f763fa9c11bf5f4d80e79f70f9485724ac23fe | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.82e-06 | 196 | 159 | 7 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | PBMC-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.82e-06 | 196 | 159 | 7 | d376168e15ec1cf618723259966c76be3698b9b0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.82e-06 | 196 | 159 | 7 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group, lineage and cell class | 6.82e-06 | 196 | 159 | 7 | 85d92bc226cc28384c30991cc4ebb02ec2e3ec99 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.82e-06 | 196 | 159 | 7 | 553c22c7d48f3b4f6f2b2f10d6e668c5ebb09e8c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.82e-06 | 196 | 159 | 7 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.82e-06 | 196 | 159 | 7 | 4a9095ba3f6709f88f32bf09184553f4bd211f43 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.05e-06 | 197 | 159 | 7 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.05e-06 | 197 | 159 | 7 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.05e-06 | 197 | 159 | 7 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.05e-06 | 197 | 159 | 7 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.05e-06 | 197 | 159 | 7 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 7.05e-06 | 197 | 159 | 7 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.05e-06 | 197 | 159 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.05e-06 | 197 | 159 | 7 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.05e-06 | 197 | 159 | 7 | 2b3cd318c988364adcba4441444045914d58fe46 | |
| ToppCell | COVID-19_Moderate-cDC|COVID-19_Moderate / disease group, cell group and cell class | 7.05e-06 | 197 | 159 | 7 | ff45a212434a1b128e1a217c6abdec6380938da9 | |
| ToppCell | normal_Lung-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.05e-06 | 197 | 159 | 7 | d051617f7cf96485715c343cff72833c2124512d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.29e-06 | 198 | 159 | 7 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | PBMC|World / Compartment, Disease Groups and Clusters | 7.29e-06 | 198 | 159 | 7 | 84f5b43dad0c57556171dbc0b799735654582ecf | |
| ToppCell | remission-Non-classical_Monocyte|World / disease stage, cell group and cell class | 7.29e-06 | 198 | 159 | 7 | 1c170655070acca00520b7cf9c510a04c0a90a8f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.29e-06 | 198 | 159 | 7 | d0371e2ca9e25727b35985940f6228f9d8e49727 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-conventional_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.29e-06 | 198 | 159 | 7 | b0e090000d1cdee4628f4ab252f6b444658f80f5 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-conventional_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.29e-06 | 198 | 159 | 7 | 99f98e240d81cfe5b485da2598f8392d7cbd9013 | |
| ToppCell | COVID-19_Severe-cDC|World / disease group, cell group and cell class | 7.29e-06 | 198 | 159 | 7 | c452334249f047265ae89dcabe7de446d968cae6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.53e-06 | 199 | 159 | 7 | fa5ad81554969fffe5e779614d071d9194a7182c | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.78e-06 | 200 | 159 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.78e-06 | 200 | 159 | 7 | f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-cDC|COVID-19_Mild / Disease, condition lineage and cell class | 7.78e-06 | 200 | 159 | 7 | b8f52e65813d331c49cdd5f354fdfec6fc8c339e | |
| ToppCell | COVID-19-COVID-19_Convalescent-Myeloid-CD16+_Monocyte|COVID-19_Convalescent / Disease, condition lineage and cell class | 7.78e-06 | 200 | 159 | 7 | f24abb2d54d6423ee886285e3c66a874ec59e1a3 | |
| ToppCell | medial-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.78e-06 | 200 | 159 | 7 | 16b00eacbea4d75cf814803d3fc0b82c2b8c0a9c | |
| ToppCell | COVID|World / Condition, Cell_class and T cell subcluster | 7.78e-06 | 200 | 159 | 7 | 04a932fe2431e7886120c219ce666f90d3030a1c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.78e-06 | 200 | 159 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class | 7.78e-06 | 200 | 159 | 7 | e7b808d8ed65343a4345fafb03015fe4f7ce302f | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, condition lineage and cell class | 7.78e-06 | 200 | 159 | 7 | 59cb0b0dee2599b3d3014b66d71d84c22b5de4b2 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.78e-06 | 200 | 159 | 7 | bc969a956f62570419a5faaf0ab0fd17b343c5ca | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.78e-06 | 200 | 159 | 7 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.78e-06 | 200 | 159 | 7 | 6a5047018b12be3bc4b55a64d42e52e96c624003 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.78e-06 | 200 | 159 | 7 | 1b5ac5b3ddd4df32e940531cc020998f8cd95c2c | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.60e-05 | 149 | 159 | 6 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.67e-05 | 150 | 159 | 6 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-05 | 152 | 159 | 6 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 155 | 159 | 6 | fa2776d258e0420b2895de1008e292ad7725dac0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 158 | 159 | 6 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 158 | 159 | 6 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 158 | 159 | 6 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 162 | 159 | 6 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 162 | 159 | 6 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.57e-05 | 162 | 159 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 162 | 159 | 6 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.66e-05 | 163 | 159 | 6 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-05 | 166 | 159 | 6 | 9fae71b0a42a9b2222453c03e0a1e83f30117ae9 | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.95e-05 | 166 | 159 | 6 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 2.95e-05 | 166 | 159 | 6 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 166 | 159 | 6 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 3.15e-05 | 168 | 159 | 6 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.26e-05 | 169 | 159 | 6 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 171 | 159 | 6 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.60e-05 | 172 | 159 | 6 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 174 | 159 | 6 | fedadde222df1952d6456f4f3413c01579146e1f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 3.84e-05 | 174 | 159 | 6 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 174 | 159 | 6 | e69a011ae9698368923223d3af3243e609c08c83 | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.03e-06 | 192 | 159 | 10 | 1332_UP | |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; HL60; HG-U133A | RGS12 ARHGEF15 ARHGAP4 MTF1 FCGRT SUGP1 SAC3D1 SNAPC4 PRRC2A | 1.05e-05 | 197 | 159 | 9 | 1767_UP |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 4805_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 7035_UP | |
| Drug | bromfenacoum | MAP4 NACA CAMSAP3 ZC3H18 HMGA1 KIAA1191 SPECC1 SCAF1 DST ATXN2 SORCS2 MACF1 CEP170B INPP5J EPB41L1 | 4.79e-05 | 644 | 159 | 15 | ctd:C013418 |
| Drug | tertiary carboxamide | 4.85e-05 | 2 | 159 | 2 | CID006419719 | |
| Drug | tetrabromobisphenol A | BOC CEBPD COL27A1 DUSP2 AKNA CAVIN3 HMGA1 EMILIN1 KIFC2 SCML4 LDB3 SLITRK2 ARAP3 NFATC4 FCGRT GPR153 AEBP2 SORCS2 | 5.30e-05 | 891 | 159 | 18 | ctd:C020806 |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 6.80e-05 | 194 | 159 | 8 | 1217_DN | |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 6.80e-05 | 194 | 159 | 8 | 2840_DN | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 7.05e-05 | 195 | 159 | 8 | 3871_DN | |
| Drug | Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A | 7.05e-05 | 195 | 159 | 8 | 1903_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.05e-05 | 195 | 159 | 8 | 5277_DN | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 5622_UP | |
| Drug | Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 3878_DN | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; HL60; HG-U133A | 7.31e-05 | 196 | 159 | 8 | 1716_DN | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 2839_UP | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 4823_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 2641_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 6758_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 6360_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 4800_DN | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; PC3; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 2100_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 2097_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HG-U133A | 8.13e-05 | 199 | 159 | 8 | 1892_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 8.13e-05 | 199 | 159 | 8 | 3430_DN | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 8.13e-05 | 199 | 159 | 8 | 1227_DN | |
| Disease | cystatin C measurement, chronic kidney disease | 2.67e-05 | 2 | 153 | 2 | EFO_0003884, EFO_0004617 | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 1.59e-04 | 4 | 153 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | cortical surface area measurement | ITCH MYCBP2 DUT CUL9 PARD3B FCHO2 IRAG1 PKMYT1 BCL11B ATXN2 RALGPS1 FOXL2NB HES4 MACF1 PRRC2A DCLK1 AGAP1 AGAP3 | 2.21e-04 | 1345 | 153 | 18 | EFO_0010736 |
| Disease | calcium measurement | MAP1A ATXN7L1 SEMA3G FCHO2 IRAG1 RGS12 BCL11B FCGRT AEBP2 MACF1 GNAS | 4.55e-04 | 628 | 153 | 11 | EFO_0004838 |
| Disease | fatty acid measurement | 4.74e-04 | 436 | 153 | 9 | EFO_0005110 | |
| Disease | Polycystic kidney disease, type 2 | 5.51e-04 | 7 | 153 | 2 | C2751306 | |
| Disease | vitamin k-dependent protein S measurement | 5.51e-04 | 7 | 153 | 2 | EFO_0020850 | |
| Disease | total blood protein measurement | 5.85e-04 | 449 | 153 | 9 | EFO_0004536 | |
| Disease | facial hair thickness measurement | 6.07e-04 | 32 | 153 | 3 | EFO_0007823 | |
| Disease | cortical thickness | KMT2B MYCBP2 CUL9 ADAMTS8 IRAG1 SPECC1 MICALL1 BCL11B ATXN2 PLXNC1 RALGPS1 FOXL2NB MACF1 AGAP1 AGAP3 | 7.02e-04 | 1113 | 153 | 15 | EFO_0004840 |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 7.33e-04 | 8 | 153 | 2 | C0887850 | |
| Disease | diastolic blood pressure, systolic blood pressure | SPEG DUT ADAMTS8 RGS12 ZNF512B TBX18 MSH6 BCL11B ATXN2 PLXNC1 BRD4 | 7.76e-04 | 670 | 153 | 11 | EFO_0006335, EFO_0006336 |
| Disease | Polycystic Kidney, Autosomal Dominant | 9.39e-04 | 9 | 153 | 2 | C0085413 | |
| Disease | multiple sclerosis | MEF2B TTC28 RASGRF1 TSPOAP1 ZNF767P USP31 NCOR2 ATXN2 PLXNC1 AGAP2 | 1.11e-03 | 594 | 153 | 10 | MONDO_0005301 |
| Disease | tauopathy (implicated_via_orthology) | 1.17e-03 | 10 | 153 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | level of Ceramide (d42:1) in blood serum | 1.17e-03 | 10 | 153 | 2 | OBA_2045187 | |
| Disease | coagulation factor XA measurement | 1.42e-03 | 11 | 153 | 2 | EFO_0020266 | |
| Disease | coagulation factor X measurement | 2.01e-03 | 13 | 153 | 2 | EFO_0020265 | |
| Disease | dystonia (is_implicated_in) | 2.33e-03 | 14 | 153 | 2 | DOID:543 (is_implicated_in) | |
| Disease | serum non-albumin protein measurement | 2.86e-03 | 361 | 153 | 7 | EFO_0004568 | |
| Disease | Cardiovascular Abnormalities | 3.06e-03 | 16 | 153 | 2 | C0243050 | |
| Disease | T-Cell Lymphoma | 3.06e-03 | 16 | 153 | 2 | C0079772 | |
| Disease | atrial fibrillation | 3.32e-03 | 371 | 153 | 7 | EFO_0000275 | |
| Disease | birth weight, parental genotype effect measurement | 3.33e-03 | 192 | 153 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | copine-1 measurement | 3.45e-03 | 17 | 153 | 2 | EFO_0008102 | |
| Disease | alcoholic liver cirrhosis | 3.45e-03 | 17 | 153 | 2 | EFO_1000802 | |
| Disease | Colorectal Carcinoma | BOC RASGRF2 TCOF1 APC2 ARHGEF10L MSH6 BCL11B ARAP3 GNAS DCLK1 | 3.73e-03 | 702 | 153 | 10 | C0009402 |
| Disease | serum albumin measurement | 3.85e-03 | 592 | 153 | 9 | EFO_0004535 | |
| Disease | loneliness measurement | 4.03e-03 | 124 | 153 | 4 | EFO_0007865 | |
| Disease | factor VIII measurement, Ischemic stroke | 4.31e-03 | 19 | 153 | 2 | EFO_0004630, HP_0002140 | |
| Disease | hemifacial microsomia | 4.31e-03 | 19 | 153 | 2 | MONDO_0015398 | |
| Disease | PR interval | 4.42e-03 | 495 | 153 | 8 | EFO_0004462 | |
| Disease | tea consumption measurement | 4.63e-03 | 129 | 153 | 4 | EFO_0010091 | |
| Disease | neutrophil percentage of leukocytes | 4.68e-03 | 610 | 153 | 9 | EFO_0007990 | |
| Disease | mean corpuscular hemoglobin concentration | TTC28 FCHO2 ZNF767P SPECC1 SH2B1 ARHGEF15 TGIF1 TTBK2 BMPR2 ATXN2 BRD4 MACF1 AGAP1 | 5.08e-03 | 1105 | 153 | 13 | EFO_0004528 |
| Disease | vital capacity | HMGA1 ADAMTS8 SH2B1 TBX18 NCOR2 DST TULP4 MTF1 NFATC4 BRD4 SNAPC4 VWA5B1 AGAP1 AGAP3 | 5.12e-03 | 1236 | 153 | 14 | EFO_0004312 |
| Disease | sexual dimorphism measurement | ITCH KMT2B RASGRF1 DUT HMGA1 NFS1 NCOR2 NFATC4 ALPK3 MACF1 MGA EPB41L1 AGAP2 | 5.12e-03 | 1106 | 153 | 13 | EFO_0021796 |
| Disease | urate measurement, bone density | 5.14e-03 | 619 | 153 | 9 | EFO_0003923, EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APCSRRPAPGKASGP | 91 | Q8WTP8 | |
| VPGKRLPRATPATAP | 426 | Q96P47 | |
| PQLRAAPPTRTPSAK | 11 | P59051 | |
| GPPGTSALPRLSRSP | 581 | P55198 | |
| RLSPLPPGSPGSAAR | 16 | Q6ZN18 | |
| RPSPRTVKSFPLAAP | 846 | Q9HCE6 | |
| AAQRSGPRAPSPTKP | 11 | Q96FF9 | |
| GPRAPSPTKPLRRSQ | 16 | Q96FF9 | |
| PGKRPPRATSACAPI | 406 | Q9UPQ3 | |
| SPVSNKAGPSPPRRG | 686 | Q8WWN8 | |
| RALSGRKGPAAPPPT | 191 | Q969G5 | |
| SRPSNRAAALPPKPA | 871 | O60885 | |
| PPPPLGATSRTKRFV | 201 | Q9UP79 | |
| RRPKLEAPPSPSLGS | 1386 | Q6F5E8 | |
| TPGPSSPRQPRKALV | 1121 | Q12774 | |
| VPPPRPASRPKLTSG | 461 | Q0JRZ9 | |
| PTVSPRGPRKSLVPG | 1391 | Q96L96 | |
| ARSKSAPRAPPGLTP | 91 | C9J069 | |
| ALAAGSPARPPPARS | 851 | C9J069 | |
| GSARKRSSPKGPPLP | 281 | Q9BYV8 | |
| VPRGPSNPRKSVSSP | 121 | Q5M775 | |
| PGKRPPRAISAFGPS | 736 | Q99490 | |
| KPPALLPPSASRASL | 71 | O94989 | |
| KLPAASPRHIRPSGP | 811 | Q8IYM0 | |
| RTPRQPPRGPSAAAK | 66 | Q8N531 | |
| ARHPASSVALKRPPP | 736 | P78325 | |
| LGSRRKPAAPPPSPA | 1076 | Q9Y4F5 | |
| KGFQPPSPSLRPRPA | 161 | Q5HYR2 | |
| GPKAASPSPARRVPA | 751 | Q9P1Y5 | |
| RAPSPSGLMSPSRLP | 1071 | Q9P1Y5 | |
| KSRPPNSVLPRPSSA | 391 | Q9ULK2 | |
| PAPARPRSPSQTRKG | 286 | P49418 | |
| PPKRSAPSGPVRSSS | 161 | P38159 | |
| AGSLPTPPVPRHRKS | 326 | Q5JS13 | |
| TAHTTGPPPKPRRSK | 1726 | O95153 | |
| AVSPRKSPRPAGPQL | 146 | Q9BUH6 | |
| PSPEPSPFGSRTKKR | 581 | Q8N612 | |
| GSSPRGKSRSPAPPA | 1016 | Q9Y618 | |
| KSPRVPRLGGKPSSP | 351 | Q8TEW8 | |
| RRLPSSPASPSPKGT | 536 | Q9H4G0 | |
| KPKRGVPTSASAPPR | 1501 | Q14667 | |
| TPGKGPADRASRAPP | 2631 | P78559 | |
| APPKRPAVASARPSI | 751 | P27816 | |
| PKGSIRPSISNPRIP | 751 | Q92805 | |
| PGPPRASLRAKTSPE | 161 | O75112 | |
| AAPGPKPAAPTRGLR | 16 | Q9Y697 | |
| PRTPAKVPTSAPSLG | 791 | Q9HCH0 | |
| FVPAKRPIAARPSPG | 1521 | Q8IWI9 | |
| PTLLRPPDGPRAASA | 716 | Q9P107 | |
| PTPRAGSRPSTAKPS | 7536 | Q03001 | |
| RQKPPAPRASGGPAL | 81 | Q6ZUU3 | |
| PSPKRTSVGSRPPAV | 346 | Q9BXM9 | |
| APPAAPTRASPLGAR | 116 | Q99700 | |
| ASPPRSGVSLARPAP | 131 | Q99700 | |
| VAKSEPARPSPGSPR | 46 | Q92952 | |
| PPALKSTPGAPRDQR | 696 | Q92615 | |
| PSPSPTSPGSLRKQR | 331 | O15075 | |
| PHTRATRTKPCGLPP | 506 | Q96HB5 | |
| APAPALPPTGDKTSR | 146 | Q05923 | |
| AGSKAELPPTVSRPP | 366 | Q9Y6F6 | |
| EPPSMRLKARPSSPG | 201 | P55899 | |
| VSLAPPARPRPGSSF | 91 | O60486 | |
| ARSPRRPGAPSLSPA | 51 | Q5QP82 | |
| RPGPGPRSASASLLP | 486 | Q6NV75 | |
| APVPSRRNPPGGKSS | 136 | Q9UK76 | |
| EGRSSSPVPPPRLKA | 106 | Q71F78 | |
| PARGGRKPSPPEAAS | 871 | Q9ULI4 | |
| KRPAPRAPSASPLAL | 476 | Q8N3F8 | |
| SPPPVVPATCSRKRG | 456 | Q9UMN6 | |
| KRPLAAPSAPTVAAP | 126 | A6NEQ2 | |
| PSTTPHSSPKQRPRG | 176 | Q96A73 | |
| PGPETPAISPSKRAR | 91 | P33316 | |
| GPRPLARSASPPKAK | 56 | P52701 | |
| LSPPPEAAPRGGRKT | 296 | Q9BZI1 | |
| SLRPPGAPATFLRPS | 286 | Q02080 | |
| RSGGRKSLSQPTPPP | 6961 | Q9UPN3 | |
| PSLSNGGFKPSRPPR | 241 | Q96J02 | |
| ATRASPPRSPAEPKG | 271 | Q5T0Z8 | |
| TSGSPRSPAGPEKPR | 1761 | O95996 | |
| SQPPRSATPPARLAK | 1856 | O95996 | |
| RKPAPLPSPGLNSAA | 671 | Q9C0K0 | |
| ARKSSGQPGRLPPPT | 811 | Q9BWV1 | |
| SSPRQTPAPGPAREK | 166 | P49716 | |
| PRSGKTPASIRKPPS | 646 | Q86XJ1 | |
| PSRAAPGKSEPPSKR | 1151 | Q4ZHG4 | |
| KAGPSPSRDLHPARP | 851 | Q8N1P7 | |
| LKLRSPDASPSRAPP | 166 | O95467 | |
| PSTAADPGPSKPRRA | 921 | Q13873 | |
| APSGLFSKRRAPGPP | 21 | B7Z1M9 | |
| ARASTSSPKPLVPRP | 61 | A6NJJ6 | |
| RSKQAGSSPRPPPGL | 1311 | Q7Z591 | |
| RPVKFPSLPRSPASS | 611 | Q68DC2 | |
| RGPRGTVAPATPTKP | 286 | Q8IZC6 | |
| PFSGTTPSRKPLPKR | 101 | A0A1B0GTR0 | |
| SPPRPRTGLPQGKKS | 96 | Q6Q6R5 | |
| GPSRRPASLSPAAPA | 151 | Q9HCC6 | |
| AALAAGPTPPGPRKR | 211 | P12980 | |
| IKVPPRSPRSTIGSP | 486 | Q9P267 | |
| SKGRDRSPAPSPVLP | 1451 | Q8IWT3 | |
| STLRGKPRPPPVSAQ | 11 | A4QMS7 | |
| LPASPAPRAARKASP | 196 | Q9NQR7 | |
| ALGPASSTPRPLARP | 136 | Q9Y6C2 | |
| SRPAAGKPRPPPSQL | 101 | A6NKF1 | |
| SLTGLPPPVSRRPGS | 21 | Q9UPN4 | |
| PPPVSRRPGSAATTK | 26 | Q9UPN4 | |
| PRLGPTPAARAAAPS | 846 | Q9UL51 | |
| PRTLPGSRHKPAPTK | 271 | Q9BTV7 | |
| VSPAAGSSPGKPPRL | 21 | P01034 | |
| KVAPAPARPSGPSKA | 211 | P48444 | |
| GSRAPPGRLLPSAPT | 766 | Q96AC6 | |
| PGTPRPLNRPKVSLS | 171 | Q9NY27 | |
| DKSRSPRSPPGKPQG | 106 | P02812 | |
| RGRPRKQPPVSPGTA | 26 | P17096 | |
| AAGTLPSPQSLRKPP | 301 | Q13368 | |
| TSTPGASPAPRSRKP | 251 | Q504T8 | |
| VSAPPKVSSGPRLPA | 76 | Q92750 | |
| PPKASRPRLSIPCSS | 311 | Q9NRF2 | |
| SPRKGAAPAPPRKTG | 446 | Q13428 | |
| TPASPRPASPCGKRR | 256 | Q14934 | |
| GKSPRLCRKFSSPPP | 716 | O14827 | |
| ASSRRKGCSSPPPPE | 646 | Q14872 | |
| SPASAGLRRNPALPP | 166 | P57071 | |
| TPPRKDAAPALGPLS | 286 | Q9H6K5 | |
| SPGRAPAPSALPRAK | 276 | Q8NGU9 | |
| PKTNSLSRPGALPPR | 406 | Q96B97 | |
| PSRASKGPGPTARAP | 6 | Q96PQ0 | |
| TPRDSAGVSPFPPKR | 1546 | P48634 | |
| PALNPTRAPKASRPP | 291 | Q9H156 | |
| PLRGRSTSPKPKSVP | 2891 | O75592 | |
| PGSRAPSPRLPNKTI | 126 | A6NGB9 | |
| PRATRKFSSPPPLSI | 731 | Q13972 | |
| PPRSRKPSKAGTAPS | 526 | A6NEL2 | |
| SPGPRSPKAPPSSRL | 901 | P98171 | |
| PATSASPPGPTLKAR | 991 | Q6ZRI6 | |
| RKPNSRPAPGVGSLP | 116 | Q96N53 | |
| APTCPRTPKPTSRGR | 176 | Q96EG3 | |
| RKSPPEALSGSLPPA | 336 | Q8IWZ8 | |
| LPKPPRSPSRSPSHS | 341 | Q15735 | |
| SPKPSSPGSVLARPS | 286 | Q15583 | |
| PSPSPRSSPRLNKGR | 111 | Q75MW2 | |
| RSPTAPFTSPLPRGK | 156 | Q96HA9 | |
| SAKACTPDGPRPRPR | 416 | Q6PCB0 | |
| PRLPLRKPSVGSPSL | 566 | Q9NRJ4 | |
| PSPTASGRAALAPRP | 276 | Q96KV7 | |
| PPASLRSSVPPSKRG | 511 | O14924 | |
| AAAVPTTPRRGRPPK | 1941 | Q96T58 | |
| SALLPPPSPRVGKRS | 306 | Q15772 | |
| KARVPTVPPRPGSSL | 2306 | Q15772 | |
| PAKGSIPISRLFPPR | 56 | Q99640 | |
| SPARSLARPGTPLPS | 121 | O95935 | |
| RGPSPAPASSPKREV | 716 | Q9H7N4 | |
| PAPGTALPAPDRKRF | 1196 | Q5XPI4 | |
| PKSPVVPRRSPSASP | 1141 | Q6IQ55 | |
| KSRSPSPRSLPPALS | 46 | Q9Y6A9 | |
| TPSRTAPGALTAKPP | 156 | Q4KMP7 | |
| SKPGPISRPVTISRP | 171 | Q96KM6 | |
| PATAPARPLRLPSGN | 2451 | Q96AY4 | |
| APLPAQGPGKARPSR | 6 | Q96CS4 | |
| PQASLLASTGPRPKP | 876 | Q5SXM2 | |
| SSGPSPGPSVPRLRL | 21 | Q9NS98 | |
| PATRSPFPPGKSRTS | 1136 | Q70CQ4 | |
| PSSRRGLNGTKPVPP | 901 | Q9Y4F4 | |
| PPRPSTPDLSKARGS | 921 | Q9Y4E6 | |
| AAPSRPGAPAAGPRK | 31 | Q96NR7 | |
| SSAGEVPKPRPPSTR | 66 | O15231 | |
| SAPGLRPPASSPKRN | 301 | Q8N228 | |
| AKHSRPASPDPTPGR | 336 | Q8WTX9 | |
| TPSPHRPSIRTKGEP | 611 | Q86VM9 | |
| RASPSRPATPAPVLG | 796 | Q5TIE3 | |
| PLASSPESARPKPRA | 4951 | O14686 | |
| TPALGPSAPQKPLRR | 841 | Q9P206 | |
| ARATPAPKGIPASPS | 921 | E9PAV3 |